The Motley Fool. DATE Wednesday, June 4, 2025 at 5 p.m. ET Read More: Earn up to $845 cash back this year just by changing ...

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

Regeneron licensed a weight loss drug and revealed study data for a pair of muscle-preserving medicines. Elsewhere, two neuroscience biotechs cut deals and Bluebird officially went private.

Potential import taxes on pharma goods entering the United States continue to have effects on the industry in more ways than ...